Anzeige
The Orphan Drug Act
The Orphan Drug Act
The Orphan Drug Act
The Orphan Drug Act
The Orphan Drug Act
The Orphan Drug Act
The Orphan Drug Act
The Orphan Drug Act
The Orphan Drug Act
The Orphan Drug Act
The Orphan Drug Act
The Orphan Drug Act
The Orphan Drug Act
The Orphan Drug Act
The Orphan Drug Act
The Orphan Drug Act
The Orphan Drug Act
The Orphan Drug Act
The Orphan Drug Act
The Orphan Drug Act

Check these out next

5. Unit-V- Regulatory Concepts.
5. Unit-V- Regulatory Concepts.
Audumbar Mali
Regulatory aspects of orphan drugs devolpments
Regulatory aspects of orphan drugs devolpments
JITHIN K JOY
A REVIEW ON DRUG APPROVAL PROCESS FOR US, EUROPE AND INDIA
A REVIEW ON DRUG APPROVAL PROCESS FOR US, EUROPE AND INDIA
International Journal of Drug Regulatory Affairs
Ind (investigational new drug application) and nda
Ind (investigational new drug application) and nda
swati2084
Orphan Drugs
Orphan Drugs
Ashish Bajaj
4. Unit-IV:- Clinical Trials.
4. Unit-IV:- Clinical Trials.
Audumbar Mali
US - FDA Regulatory Agency Overview.
US - FDA Regulatory Agency Overview.
Venugopal N
Orange book
Orange book
Rucha Pathak
1 von 20

The Orphan Drug Act

7. Feb 2011••
Downloaden Sie, um offline zu lesen

Abbreviated Review of The Orphan Drug Act

biotechpro
Anzeige
Anzeige
Anzeige

Recomendados

What is an orphan drug?What is an orphan drug?
What is an orphan drug?Peder S. Andersen930 Aufrufe•10 Folien
Orphan DrugsOrphan Drugs
Orphan DrugsJaideep Patel2.1K Aufrufe•32 Folien
Orphan DrugsOrphan Drugs
Orphan DrugsANCY JOSE12.5K Aufrufe•21 Folien
Usa and canada ppt final ranju hod augstUsa and canada ppt final ranju hod augst
Usa and canada ppt final ranju hod augstRanjiniDM2K Aufrufe•51 Folien
NEW POWER POINT PRESENTATION ON ORPHAN DISEASES AND DRUGSNEW POWER POINT PRESENTATION ON ORPHAN DISEASES AND DRUGS
NEW POWER POINT PRESENTATION ON ORPHAN DISEASES AND DRUGSManukonda sravani Reddy803 Aufrufe•22 Folien
Orphan DrugsOrphan Drugs
Orphan Drugspatrickconneran8.8K Aufrufe•18 Folien

Más contenido relacionado

Presentaciones para ti(20)

5. Unit-V- Regulatory Concepts.5. Unit-V- Regulatory Concepts.
5. Unit-V- Regulatory Concepts.
Audumbar Mali•14.7K Aufrufe
Regulatory aspects of orphan drugs devolpmentsRegulatory aspects of orphan drugs devolpments
Regulatory aspects of orphan drugs devolpments
JITHIN K JOY•420 Aufrufe
A REVIEW ON DRUG APPROVAL PROCESS FOR US, EUROPE AND INDIAA REVIEW ON DRUG APPROVAL PROCESS FOR US, EUROPE AND INDIA
A REVIEW ON DRUG APPROVAL PROCESS FOR US, EUROPE AND INDIA
International Journal of Drug Regulatory Affairs•11.1K Aufrufe
Ind (investigational new drug application) and ndaInd (investigational new drug application) and nda
Ind (investigational new drug application) and nda
swati2084•90K Aufrufe
Orphan DrugsOrphan Drugs
Orphan Drugs
Ashish Bajaj•1.8K Aufrufe
4. Unit-IV:- Clinical Trials.4. Unit-IV:- Clinical Trials.
4. Unit-IV:- Clinical Trials.
Audumbar Mali•10.3K Aufrufe
US - FDA Regulatory Agency Overview.US - FDA Regulatory Agency Overview.
US - FDA Regulatory Agency Overview.
Venugopal N•4.2K Aufrufe
Orange bookOrange book
Orange book
Rucha Pathak•26.2K Aufrufe
Orphan drugs development.Orphan drugs development.
Orphan drugs development.
pratik9527088941•264 Aufrufe
Regulatory guidelines of AustraliaRegulatory guidelines of Australia
Regulatory guidelines of Australia
nandiniwarier93•6.1K Aufrufe
Orphan Drug DesignationOrphan Drug Designation
Orphan Drug Designation
National Alopecia Areata Foundation•2.4K Aufrufe
regulatory approval process of drug, cosmetic and herbals in canada regulatory approval process of drug, cosmetic and herbals in canada
regulatory approval process of drug, cosmetic and herbals in canada
Richa Patel•3.7K Aufrufe
IND INDA ANDA ApplicationIND INDA ANDA Application
IND INDA ANDA Application
ROSHAN BODHE•3.5K Aufrufe
ORPHAN DRUGS- ACTS, PAST AND CURRENT SCENARIO, WITH UPCOMING DRUGSORPHAN DRUGS- ACTS, PAST AND CURRENT SCENARIO, WITH UPCOMING DRUGS
ORPHAN DRUGS- ACTS, PAST AND CURRENT SCENARIO, WITH UPCOMING DRUGS
Ashish Bajaj•4.7K Aufrufe
Regulatory approval and system of drug master file ,IND and NDA in USARegulatory approval and system of drug master file ,IND and NDA in USA
Regulatory approval and system of drug master file ,IND and NDA in USA
sandeep bansal•885 Aufrufe
Regulations for drug approval in USA, E.U & IndiaRegulations for drug approval in USA, E.U & India
Regulations for drug approval in USA, E.U & India
Dr. Pankaj Bablani•54.2K Aufrufe
Generics And InnovatorsGenerics And Innovators
Generics And Innovators
Sachin Kothawade•3.6K Aufrufe
Orphan drugsOrphan drugs
Orphan drugs
drarunsingh4•1.2K Aufrufe
Who prequalification programWho prequalification program
Who prequalification program
shweta more•3.3K Aufrufe
Contract Research Organisations- CRO in Pharma FieldContract Research Organisations- CRO in Pharma Field
Contract Research Organisations- CRO in Pharma Field
VINOTH R•1.6K Aufrufe

Similar a The Orphan Drug Act(20)

The science of hopeThe science of hope
The science of hope
Freedom Monk•630 Aufrufe
Ethical Implications of Orphan Drug Research IncentivesEthical Implications of Orphan Drug Research Incentives
Ethical Implications of Orphan Drug Research Incentives
Kuldeep Badoniya•64 Aufrufe
Top Trends in Orphan DrugsTop Trends in Orphan Drugs
Top Trends in Orphan Drugs
Bill Smith•1.3K Aufrufe
MMHA 6135 WK 5 AppMMHA 6135 WK 5 App
MMHA 6135 WK 5 App
Danielle Tate•78 Aufrufe
Orphan Drug ReportOrphan Drug Report
Orphan Drug Report
Bill Smith•1.4K Aufrufe
Rajasimha-ORDI-RareDiseasePolicy-ODA-Delhi-22Apr2016Rajasimha-ORDI-RareDiseasePolicy-ODA-Delhi-22Apr2016
Rajasimha-ORDI-RareDiseasePolicy-ODA-Delhi-22Apr2016
Harsha Rajasimha•262 Aufrufe
Read Logica’s paper on the need for convergence of healthcare and pharmaRead Logica’s paper on the need for convergence of healthcare and pharma
Read Logica’s paper on the need for convergence of healthcare and pharma
CGI•829 Aufrufe
Orphan Drugs – High Prices: Is there a Way Forward?Orphan Drugs – High Prices: Is there a Way Forward?
Orphan Drugs – High Prices: Is there a Way Forward?
Office of Health Economics•224 Aufrufe
Lisman New ParadigmsLisman New Paradigms
Lisman New Paradigms
jalisman•128 Aufrufe
Health Exchange: Access to medicines April 2010Health Exchange: Access to medicines April 2010
Health Exchange: Access to medicines April 2010
HealthlinkWorldwide•253 Aufrufe
Consumer health: time for a regulatory re-think?Consumer health: time for a regulatory re-think?
Consumer health: time for a regulatory re-think?
The Economist Media Businesses•393 Aufrufe
Twillman preventing rx abuseTwillman preventing rx abuse
Twillman preventing rx abuse
American Academy of Family Physicians•334 Aufrufe
Development of drugs in public-private partnership (PPP) environmentsDevelopment of drugs in public-private partnership (PPP) environments
Development of drugs in public-private partnership (PPP) environments
pmaugeri•884 Aufrufe
Clinical Trials In Developing Countries Unethical Practice Or A Product Of N...Clinical Trials In Developing Countries Unethical Practice Or A Product Of N...
Clinical Trials In Developing Countries Unethical Practice Or A Product Of N...
Dr Aneek Gupta•575 Aufrufe
Zweig powerpoint on Palliative Care in Nursing Homes for Theme Session co-spo...Zweig powerpoint on Palliative Care in Nursing Homes for Theme Session co-spo...
Zweig powerpoint on Palliative Care in Nursing Homes for Theme Session co-spo...
MedicineAndHealthUSA•2.7K Aufrufe
The High Prices of Prescription Drugs Increase Costs for EveryoneThe High Prices of Prescription Drugs Increase Costs for Everyone
The High Prices of Prescription Drugs Increase Costs for Everyone
America's Health Insurance Plans•1.8K Aufrufe
Proper prescribing module1_revised v2Proper prescribing module1_revised v2
Proper prescribing module1_revised v2
bahlinnm•1.3K Aufrufe
Demonstrating Significant Benefit for an OMPDemonstrating Significant Benefit for an OMP
Demonstrating Significant Benefit for an OMP
Mauro Placchi•278 Aufrufe
RF 2016 07 Health Technology AssessmentRF 2016 07 Health Technology Assessment
RF 2016 07 Health Technology Assessment
Richard Phillips•224 Aufrufe
Directed ProjectDirected Project
Directed Project
Krishna Yanamandra•162 Aufrufe
Anzeige

The Orphan Drug Act

  1. The Orphan Drug Act Jeff W. Bailey MS Senior Regional Business Manager Shire Human Genetic Therapies June 2009
  9. Findings: Total Orphan Designations and Approvals 68 79 67 55 60 56 58 65 56 80 89 75 73 59 33 48 41 1 D E S I G N A T E 14 20 20 19 23 11 11 13 13 12 12 12 11 9 6 7 3 2 A P P R O V A L S 00 99 98 97 96 95 94 93 92 91 90 89 88 87 86 85 84 83 Y E A R
Anzeige